Section 3(d) Archives - Page 2 of 19 - GIP Research & Consultancy Services

Patent granted in India to DOW GLOBAL TECHNOLOGIES LLC

September 4, 2021

patent number 375303 has been granted to DOW GLOBAL TECHNOLOGIES LLC that is titled PROCESS FOR PREPARING MULTI- OR DUAL-HEADED COMPOSITIONS USEFUL FOR CHAIN SHUTTLING. The patent applicant responded to this objection by stating that the claimed process for preparing a composition defines novel and non-obvious technical features and therefore cannot be considered as a mere use of a “known” process as disclosed in the cited references. This patent falls under the category of Chemical. Overall, this patent covers a process for synthesizing a multi or dual headed composition by using an alpha, omega-diene and an organometallic compound in the presence of a catalyst precursor. The present disclosure further relates to use of the compositions, as well as the process to make the same, in olefin polymerization.

Patent granted in India to JENNEWEIN BIOTECHNOLOGIE GMBH

August 31, 2021

Patent number 374974 has been granted to JENNEWEIN BIOTECHNOLOGIE GMBH that is titled PROCESS FOR PURIFICATION OF A NEUTRAL HUMAN MILK OLIGOSACCHARIDE USING SIMULATED MOVING BED CHROMATOGRAPHY. The patent applicant responded to this objection by stating that amended claims of the present invention are a novel process and not a mere use of known process. This patent falls under the category of Chemical. Overall, this patent covers a process for purification of a neutral human milk oligosaccharide in a continuous chromatography from a crude solution comprising the neutral human milk oligosaccharide and contaminants, wherein the crude solution comprising the neutral human milk oligosaccharide and contaminants comprises or consists of a solution which is selected from the group consisting of microbial fermentation extract, biocatalysis reaction solution, chemical synthesis solution, and combinations thereof, wherein the purity of the neutral human milk oligosaccharide in the solution is <80 %, characterized in that the crude solution is applied to at least one purification step using simulated moving bed chromatography, wherein a purified solution comprising the neutral human milk oligosaccharide with a purity of 80 % is provided and wherein the purified solution is spray-dried, and neutral HMO is selected from the group consisting of 2’- fucosyllactose, 3-fucosyllactose, 2’,3-difucosyllactose, lacto-N-triose II, lacto-Ntetraose, lacto-N-neotetraose, lacto-N-fucopentaose I, lacto-N-neofucopentaose I, lacto-N-fucopentaose II, lacto-N-fucopentaose III, lacto-N-fucopentaose V, lactoN-neofucopentaose V, lacto-N-difucohexaose I, lacto-N-difucohexaose II, 6’- galactosyllactose, 3’-galactosyllactose, lacto-N-hexaose, lacto-N-neohexaose, para-lacto-N-hexaose, para-lacto-N-neohexaose and difucosyl-lacto-N-neohexaose, most preferably, the neutral HMO is 2´-fucosyllactose or lacto-N-tetraose.

Patent granted in India to PFIZER INC.

Patent number 374862 has been granted to PFIZER INC. that is titled NEISSERIA MENINGITIDIS COMPOSITIONS AND METHODS THEREOF. The patent applicant responded to this objection by stating that in the present invention, the composition as claimed in the amended claims of the instant invention are novel and inventive in view of the prior art documents. This patent falls under the category of Chemical. Overall, this patent covers stable formulations of Neisseria meningitis Subfamily B factor H binding protein (fHBP) antigens in immunogenic compositions.

Patent granted in India to INDOFIL CHEMICALS COMPANY (A DIVISION OF INDOFIL ORGANIC INDUSTRIES LTD.)

August 23, 2021

Patent number 373917 has been granted to INDOFIL CHEMICALS COMPANY (A DIVISION OF INDOFIL ORGANIC INDUSTRIES LTD) that is titled SYNERGISTIC FUNGICIDAL COMPOSITION. The patent applicant responded to this objection by stating that the claims of the present disclosure are directed to fungicidal composition and that the learned Controller has not raised any novelty objections for claims indicating that the Controller acknowledges the novelty of said invention. This patent falls under the category of Agrochemical. Overall, this patent covers a fungicidal composition containing bio-effective amounts of Dithiocarbamate with Triazole. Dithiocarbamate used is Mancozeb and triazole used is Hexaconazole is a preferred triazole.

Patent granted in India to DHANUKA AGRITECH LIMITED

August 21, 2021

Patent number 374065 has been granted to DHANUKA AGRITECH LIMITED that is titled SYNERGISTIC HERBICIDAL FORMULATION COMPRISING COMBINATION OF HALOSULFURON METHYL AND METRIBUZIN FOR CONTROL OF SEDGES, NARROW AND BROAD LEAF WEEDS IN SUGARCANE. The primary independent claim of this patent states a synergistic herbicidal formulation having a combination of Halosulfuron methyl in an amount 6% by weight of the formulation, Metribuzin in an amount 50% by weight of the formulation and one agrochemical acceptable excipient. During the patent prosecution, the patent examiner objected to this patent under section 3(d) of the Indian Patents Act. The patent applicant responded to this objection by stating that in the present invention, the composition of present invention includes a technical differentiating feature, combination of Halosulfuron methyl in an amount 6% by weight of the formulation and Metribuzin in an amount 50% by weight of the formulation. This patent falls under the category of Chemical. Overall, this patent covers a synergistic herbicidal formulation having a combination of Halosulfuron methyl in an amount of 6% by weight of the formulation, Metribuzin in an amount of 50% by weight of the formulation, and at least one agrochemical acceptable excipient for the control of sedges, narrow leaf weeds and broadleaf weeds in Sugarcane. The formulation can be applied as pre-emergence or post-emergence.

Patent granted in India to INDIAN INSTITUTE OF TECHNOLOGY KANPUR

August 18, 2021

patent number 373162 has been granted to INDIAN INSTITUTE OF TECHNOLOGY KANPURthat is titled NANOPARTICLE-BASED DRUG DELIVERY SYSTEM FOR NICLOSAMIDE AND A COMBINATION THEREOF. The patent applicant responded to this objection by stating that section 3(d) does not apply to the present compounds and that the technical merit of the present invention is further substantiated by embodiments of the present invention. This patent falls under the category of Chemical. Overall, this patent covers a nanoparticle-based drug delivery system for Niclosamide wherein a nanoparticle-based combinatorial drug delivery system comprises a synergistic combination of Niclosamide loaded nanoparticles 15 and Doxorubicin loaded nanoparticles for leads to death of all clinical subtypes of breast cancer cells can be used for treating other cancer types as well covering multiple cancers such as colorectal cancer, prostate cancer, breast cancer, melanoma, gastrointestinal cancer, osteosarcoma, leukemia, glioblastoma, lung cancer, hepatocellular carcinoma, ovarian cancer, pancreatic cancer etc.

Patent granted in India to NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH (NIPER)

Patent number 373139 has been granted to NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH (NIPER) that is titled CAN IMPROVED PROCESS FOR THE PREPARATION OF SULFONYLUREAS. The primary independent claim of this patent states a process to produce compound and salts thereof by reacting a compound of the formula with an acyclic carbonate ester compound in the presence of first solvent and at an appropriate temperature to form a mixture and further extracting the mixture obtained, with an organic solvent to separate the extracts of compounds of the formula II. The patent applicant responded to this objection by stating that in the present invention, the carbamate can be prepared by reacting an amine with an acyclic carbonate ester in aqueous or aqueous-organic solvents without using any base. This patent falls under the category of Chemical. Overall, this patent covers a process for the preparation of sulfonylurea compounds of formula I as anti-diabetic agents with high purity and yield and without the use of any hazardous reagents.

Patent granted in India to PFIZER INC

August 7, 2021

Patent number 372466 has been granted to PFIZER INC. that is titled SUBSTITUTED DIHYDROISOQUINOLINONE COMPOUNDS. The primary independent claim of this patent states a compound of formula, or a pharmaceutically acceptable salt thereof. During the patent prosecution, the patent examiner objected to this patent under section 3(d) of the Indian Patents Act. The patent applicant responded to this objection by stating that Section 3(d) does not apply to all pharmaceutical and chemical inventions.

Patent granted in India to TEIJIN PHARMA LIMITED

Patent number 372415 has been granted to TEIJIN PHARMA LIMITED that is titled CRYSTAL OF AZOLE BENZENE DERIVATIVE. The patent applicant responded to this objection by stating that section 3(d) does not apply to the present compounds, as the claimed compound is a novel compound and the claims relate to a crystal form of a novel compound, and therefore the claimed crystal form is a novel form of a novel compound. This patent falls under the category of Chemical. Overall, this patent covers The present invention relates to a crystal of 2-[-4-(2,2-dimethylpropoxy)-3-(1H-1,2,3,4-tetrazol-lyl)phenyl]-4-methyl-1,3-thiazole-5-carboxylic acid.

Patent granted in India to E I DU PONT DE NEMOURS and ARCHER DANIELS MIDLAND COMPANY

July 31, 2021

Patent number 372057 has been granted to E I DU PONT DE NEMOURS and ARCHER DANIELS MIDLAND COMPANY that is titled PROCESSES FOR PRODUCING 2,5-FURANDICARBOXYLIC ACID AND DERIVATIVES THEREOF AND POLYMERS MADE THEREFROM. The primary independent claim of this patent states an integrated process for producing 2,5-furandicarboxylic acid and/or a derivative thereof from a six-carbon sugar-containing feed that is dehydrated in the presence of a bromine source and of a solvent, at an elevated temperature and for a time sufficient to generate an oxidation feed of at least one of 5-hydroxymethylfurfural and/or a derivative or derivatives of 5-hydroxymethylfurfural in the solvent, together with at least one bromine containing species and contacting the oxidation feed with a homogenous metal catalyst based on Co and Mn and with an oxygen source at an elevated temperature for a time sufficient to produce an oxidation product mixture of 2,5-furandicarboxylic acid (FDCA) and/or a derivative thereof, the solvent, and a residual catalyst. The patent applicant responded to this objection by stating that the present invention is novel and is not published in any of the prior arts. This patent falls under the category of Chemical. Overall, this patent covers the process for producing 2,5-furandicarboxylic acid and derivatives thereof and polymers made therefrom.

GIP Research & Consultancy Services

Tag: Section 3(d)